Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05354791 · ClinicalTrials.gov registry record
Pre-post Spinal Popliteal Block
A clinical trial, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- 1,500
- Enrollment target
NCT05354791: Clinical Trial study, sponsored by Hospital for Special Surgery, New York.
NCT05354791 is a clinical trial that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 1,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05354791 was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- 1,500 participants
- Enrollment target
Study Summary
This is a retrospective chart review to determine the non-inferiority of performing lower extremity peripheral nerve block placement under spinal anesthesia compared to its pre-spinal counterpart.
Primary Outcome
Definition of abnormal neuropathic symptoms including numbness, tingling, burning, or pain sensation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2023-03-01 |
Why NCT05354791 stopped before completion
NCT05354791 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05354791 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05354791 about?
NCT05354791 is a clinical study titled "Pre-post Spinal Popliteal Block". This is a retrospective chart review to determine the non-inferiority of performing lower extremity peripheral nerve block placement under spinal anesthesia compared to its pre-spinal counterpart.
What is the current status of trial NCT05354791?
This trial is currently terminated. The enrollment target is 1,500 participants. The study started on 2021-05-01. Estimated completion is 2023-03-01.
Who is sponsoring clinical trial NCT05354791?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI